hackettg

Following the recommendations made by the Independent Medicines and Medical Devices Safety Review and the outcome of a recent public consultation on Original pack dispensing and supply of medicines containing sodium valproate, changes to Human Medicines Regulations 2023 come into effect on the 11th October that mandate full pack dispensing of all licensed medicines containing valproate (see exemption [...]

The post All valproate containing products reclassified as special containers from October 2023 appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Drug alert number:EL (23)A/37 Date issued: 27 September 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Company name: Max Remedies Ltd [...]

The post Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – October 2023 appeared first on Community Pharmacy England.

Community Pharmacy England has become aware of a discrepancy in the pack size listings for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension. This suspension is currently marketed in 100ml and 250ml pack sizes by Bayer Plc. However, these volumes represent the actual bottle sizes and not the final reconstituted volumes of the product. This may create confusion [...]

The post Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension pack size discrepancy appeared first on Community Pharmacy England.

Drug alert number: EL (23)A/34 Date issued: 5 September 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Evorel Sequi (Theramex HQ UK Ltd) PL 49105/0010 SNOMED Code: 3217311000001104 Batch Number Expiry Date Pack Size First Distributed 6029403 July 2024 8 patches 13th June 2023 Active Pharmaceutical [...]

The post Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) appeared first on Community Pharmacy England.